Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Mar;41(3):e15195.
doi: 10.1111/dme.15195. Epub 2023 Aug 23.

The diabetes management experiences questionnaire: Psychometric validation among adults with type 1 diabetes

Collaborators, Affiliations
Randomized Controlled Trial

The diabetes management experiences questionnaire: Psychometric validation among adults with type 1 diabetes

Christel Hendrieckx et al. Diabet Med. 2024 Mar.

Abstract

Aims: To examine the psychometric properties of the Diabetes Management Experiences Questionnaire (DME-Q). Adapted from the validated Glucose Monitoring Experiences Questionnaire, the DME-Q captures satisfaction with diabetes management irrespective of treatment modalities.

Methods: The DME-Q was completed by adults with type 1 diabetes as part of a randomized controlled trial comparing hybrid closed loop (HCL) to standard therapy. Most psychometric properties were examined with pre-randomization data (n = 149); responsiveness was examined using baseline and 26-week follow-up data (n = 120).

Results: Pre-randomization, participants' mean age was 44 ± 12 years, 52% were women. HbA1c was 61 ± 11 mmol/mol (7.8 ± 1.0%), diabetes duration was 24 ± 12 years and 47% used an insulin pump prior to the trial. A forced three-factor analysis revealed three expected domains, that is, 'Convenience', 'Effectiveness' and 'Intrusiveness', and a forced one-factor solution was also satisfactory. Internal consistency reliability was strong for the three subscales ( α range = 0.74-0.84) and 'Total satisfaction' ( α = 0.85). Convergent validity was demonstrated with moderate correlations between DME-Q 'Total satisfaction' and diabetes distress (PAID: rs = -0.57) and treatment satisfaction (DTSQ; rs = 0.58). Divergent validity was demonstrated with a weak correlation with prospective/retrospective memory (PRMQ: rs = -0.16 and - 0.13 respectively). Responsiveness was demonstrated, as participants randomized to HCL had higher 'Effectiveness' and 'Total satisfaction' scores than those randomized to standard therapy.

Conclusions: The 22-item DME-Q is a brief, acceptable, reliable measure with satisfactory structural and construct validity, which is responsive to intervention. The DME-Q is likely to be useful for evaluation of new pharmaceutical agents and technologies in research and clinical settings.

Keywords: person-reported outcome; psychometric validation; treatment satisfaction; type 1 diabetes.

PubMed Disclaimer

References

REFERENCES

    1. TanenbaumML, HanesSJ, MillerKM, NaranjoD, BensenR, HoodKK. Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets. Diabetes Care. 2017;40:181-187.
    1. Gonder-FrederickLA, ShepardJA, GrabmanJH, RitterbandLM. Psychology, technology, and diabetes management. Am Psychol. 2016;71:577-589.
    1. McAuleySA, deBockMI, SundararajanV, et al. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol. BMJ Open. 2018;8:e020274.
    1. SpeightJ, ChoudharyP, WilmotEG, et al. Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: a narrative review. Diabet Med. 2023;40:e14944.
    1. Martin-DelgadoJ, GuilabertM, Mira-SolvesJ. Patient-reported experience and outcome measures in people living with diabetes: a scoping review of instruments. The Patient - Patient-Centered Outcomes Research. 2021;14:759-773.

Publication types

LinkOut - more resources